GRIN2A and attention deficit-hyperactivity disorder: It is thus presumed that preferential targeting of GluN1-GluN2A/B NMDARs would be a more appropriate approach in regard to alleviating ADHD symptoms, and these types of the receptor should be given the most attention in further studies.